Cargando…
Hematopoietic Cell Transplantation for Adenosine Deaminase Severe Combined Immunodeficiency—Improved Outcomes in the Modern Era
Current treatment for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID) includes enzyme replacement therapy (ERT), allogeneic hematopoietic stem cell transplant (HSCT), or ex vivo corrected autologous hematopoietic stem cell gene therapy. Historic data show HSCT survival is...
Autores principales: | Ghimenton, Elisabetta, Flinn, Aisling, Lum, Su Han, Leahy, Timothy R., Nademi, Zohreh, Owens, Stephen, Williams, Eleri, Flood, Terrence, Hambleton, Sophie, Slatter, Mary, Gennery, Andrew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166891/ https://www.ncbi.nlm.nih.gov/pubmed/35288820 http://dx.doi.org/10.1007/s10875-022-01238-0 |
Ejemplares similares
-
Outcome of Hematopoietic Stem Cell Transplantation in patients with Mendelian Susceptibility to Mycobacterial Diseases
por: Radwan, Nesrine, et al.
Publicado: (2021) -
Adenosine deaminase deficiency: a review
por: Flinn, Aisling M., et al.
Publicado: (2018) -
TCRαβ-Depleted Haploidentical Grafts Are a Safe Alternative to HLA-Matched Unrelated Donor Stem Cell Transplants for Infants with Severe Combined Immunodeficiency
por: Tsilifis, Christo, et al.
Publicado: (2022) -
Haploidentical CD3(+) TCR αβ/CD19(+)–depleted HSCT for MHC class II deficiency and persistent SARS-CoV-2 pneumonitis
por: Ramanathan, Subramaniam, et al.
Publicado: (2022) -
Conditioning Regimens for Hematopoietic Cell Transplantation in Primary Immunodeficiency
por: Lum, S. H., et al.
Publicado: (2019)